MARATTO

article · Journal of Radiotherapy in Practice

Dosimetry evaluation of <sup>192</sup>Ir Flexisource using gafchromic EBT3 film

20243 citationsOpen accessUniversité Sultan Moulay Slimane

Abstract

Abstract Introduction: Brachytherapy is a widely used cancer treatment technique requiring precise dose delivery for optimal outcomes. This study evaluates the dosimetric properties of the ${{\rm{\;}}^{192}}$ Ir Flexisource using Gafchromic EBT3 film, adhering to American Association of Physicists in Medicine guidelines. Methods: The EBT3 film was calibrated with a linear accelerator to establish the relationship between optical density and absorbed dose. Measurements were conducted in a water-equivalent solid phantom to simulate human tissue. The dosimetric properties measured included the dose rate constant, radial dose function and anisotropy function. Results: The results showed a close alignment with reference data: a maximum deviation of 3·1% for the dose rate constant, 2·3% for the radial dose function and 5·67% for the anisotropy function. These deviations are within acceptable limits, indicating high accuracy. Conclusions: Gafchromic EBT3 film demonstrates reliable dosimetric measurement in high-dose rate brachytherapy. The film’s accuracy in evaluating the ${{\rm{\;}}^{192}}$ Ir Flexisource ensures precise treatment delivery and enhances patient safety, supporting its continued use in clinical practice.

Research topics

  • Advanced Radiotherapy Techniques
  • Radiation Therapy and Dosimetry
  • Medical Imaging Techniques and Applications

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1017/s1460396924000177

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.